Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | Defactinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 2955 | 377 | 0.3061 | 0.3267 | 0.1276 | 0.1321 |
COLO 858 | Vemurafenib | Defactinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 3197 | 423 | 0.3293 | 0.3267 | 0.1323 | 0.1321 |
COLO 858 | Vemurafenib | Defactinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 3362 | 459 | 0.3447 | 0.3267 | 0.1365 | 0.1321 |
COLO 858 | Vemurafenib | Defactinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 2189 | 432 | 0.2086 | 0.2262 | 0.1974 | 0.1950 |
COLO 858 | Vemurafenib | Defactinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 2428 | 436 | 0.2365 | 0.2262 | 0.1796 | 0.1950 |
COLO 858 | Vemurafenib | Defactinib | 0.100 | 1.000 | uM | 72 | hr | 3 | 2483 | 517 | 0.2334 | 0.2262 | 0.2082 | 0.1950 |
COLO 858 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 1382 | 879 | 0.0597 | 0.0598 | 0.6360 | 0.6178 |
COLO 858 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 1411 | 883 | 0.0627 | 0.0598 | 0.6258 | 0.6178 |
COLO 858 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 1178 | 697 | 0.0571 | 0.0598 | 0.5917 | 0.6178 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 2594 | 352 | 0.2662 | 0.2820 | 0.1357 | 0.1635 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 2796 | 541 | 0.2677 | 0.2820 | 0.1935 | 0.1635 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 3134 | 506 | 0.3120 | 0.2820 | 0.1615 | 0.1635 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 2278 | 812 | 0.1741 | 0.1578 | 0.3565 | 0.3985 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 2179 | 931 | 0.1482 | 0.1578 | 0.4273 | 0.3985 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 0.316 | uM | 72 | hr | 3 | 2164 | 891 | 0.1511 | 0.1578 | 0.4117 | 0.3985 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 1692 | 781 | 0.1082 | 0.1083 | 0.4616 | 0.4526 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 1.000 | uM | 72 | hr | 2 | 1784 | 762 | 0.1213 | 0.1083 | 0.4271 | 0.4526 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 1514 | 710 | 0.0955 | 0.1083 | 0.4690 | 0.4526 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1059 | 843 | 0.0256 | 0.0309 | 0.7960 | 0.7785 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 1234 | 950 | 0.0337 | 0.0309 | 0.7699 | 0.7785 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 1219 | 938 | 0.0334 | 0.0309 | 0.7695 | 0.7785 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 2082 | 1092 | 0.1175 | 0.1167 | 0.5245 | 0.5321 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 1969 | 1061 | 0.1078 | 0.1167 | 0.5389 | 0.5321 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 2252 | 1200 | 0.1249 | 0.1167 | 0.5329 | 0.5321 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 1557 | 1149 | 0.0484 | 0.0451 | 0.7380 | 0.7585 |